>>> Actavis Guides inital FY14 Rev $10B+ v $10.5Be; Expecting the generics marke Actavis Guides inital FY14 Rev $10B+ v $10.5Be; Expecting the generics market to grow - JP morgan healthcare conf presentation - FY14 guidance assumes divestiture of certain Western Europe businesses.